Zoetis Inc. Goodwill, Period Increase (Decrease)
Zoetis Inc. (ZTS) reported Goodwill, Period Increase (Decrease) of $7.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-12.
Financial Statements › Notes › Goodwill and Other
us-gaap:GoodwillPeriodIncreaseDecrease · last filed 2026-02-12
- Zoetis Inc. goodwill, period increase (decrease) for the quarter ending 2023-12-31 was $45.00M, a 2.27% increase year-over-year.
- Zoetis Inc. goodwill, period increase (decrease) for the quarter ending 2023-09-30 was -$6.00M.
- Zoetis Inc. goodwill, period increase (decrease) for the quarter ending 2023-06-30 was $0.00.
- Zoetis Inc. goodwill, period increase (decrease) for the quarter ending 2023-03-31 was -$1.00M.
- Zoetis Inc. goodwill, period increase (decrease) for fiscal 2025 was $7.00M.
- Zoetis Inc. goodwill, period increase (decrease) for fiscal 2023 was $38.00M, a 63.81% decline from fiscal 2022.
- Zoetis Inc. goodwill, period increase (decrease) for fiscal 2022 was $105.00M, a 3400.00% increase from fiscal 2021.
- Zoetis Inc. goodwill, period increase (decrease) for fiscal 2021 was $3.00M, a 96.00% decline from fiscal 2020.
| Period end | Goodwill, Period Increase (Decrease) 3 month | Goodwill, Period Increase (Decrease) 6 month | Goodwill, Period Increase (Decrease) 9 month | Goodwill, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2025-12-31 | $7.00M 10-K · filed 2026-02-12 | |||
| 2023-12-31 | $45.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $39.00M derived: sum of 2 quarters · filed 2025-02-13 | $39.00M derived: sum of 3 quarters · filed 2025-02-13 | $38.00M 10-K · filed 2025-02-13 |
| 2023-09-30 | -$6.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$6.00M derived: sum of 2 quarters · filed 2023-11-02 | -$7.00M 10-Q · filed 2023-11-02 | $37.00M derived: sum of 4 quarters · filed 2024-02-13 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$1.00M 10-Q · filed 2023-08-08 | $43.00M derived: sum of 3 quarters · filed 2024-02-13 | $43.00M derived: sum of 4 quarters · filed 2024-02-13 |
| 2023-03-31 | -$1.00M 10-Q · filed 2023-05-04 | $43.00M derived: sum of 2 quarters · filed 2024-02-13 | $43.00M derived: sum of 3 quarters · filed 2024-02-13 | |
| 2022-12-31 | $44.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | $44.00M derived: sum of 2 quarters · filed 2024-02-13 | $105.00M 10-K · filed 2024-02-13 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $61.00M 10-Q · filed 2022-11-03 | ||
| 2022-06-30 | $61.00M 10-Q · filed 2022-08-04 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $2.00M derived: sum of 2 quarters · filed 2023-02-14 | $2.00M derived: sum of 3 quarters · filed 2023-02-14 | $3.00M 10-K · filed 2023-02-14 |
| 2021-09-30 | $2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $2.00M derived: sum of 2 quarters · filed 2021-11-04 | $3.00M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $1.00M 10-Q · filed 2021-08-05 | ||
| 2021-03-31 | $1.00M 10-Q · filed 2021-05-06 | |||
| 2020-12-31 | $75.00M 10-K · filed 2022-02-15 | |||
| 2019-12-31 | $102.00M 10-K · filed 2021-02-16 | |||
| 2018-12-31 | $1.02B 10-K · filed 2020-02-13 | |||
| 2017-12-31 | $17.00M 10-K · filed 2019-02-14 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | $16.00M 10-K · filed 2018-02-15 | ||
| 2016-10-02 | $16.00M 10-Q · filed 2016-11-03 | |||
| 2015-12-31 | $505.00M 10-K · filed 2017-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |